{"name":"Poxel SA","slug":"poxel-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbEVSM3pJY04xM19tc0MtbEw0UnliYTJwc2xTbGJYRjNOOTkyUXpEVUtQM3RMcjNmS1lsU1dPRk5EN0pKRWtYUHNLOXpCTWJCY1A2c3VsNGs4U3l4eFYxUldfQnU0M1cxRGNZOG1JMVY1TjNPOHNCUG93dnl2ajcxampiRUJ3dVI3amdsUGFmX2JMLVJiZUdvLXpUVGZKSjBNZW5IWUw1OGUxeTJ4bUh0ZDNaSnlYZ0xlVlJsYU5mTVAzRF9VVjRHTQ?oc=5","date":"2026-03-31","type":"pipeline","source":"Contract Pharma","summary":"Poxel Sells Kidney‑Disease Drug Candidate to Scynexis for Up to $196 Million - Contract Pharma","headline":"Poxel Sells Kidney‑Disease Drug Candidate to Scynexis for Up to $196 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQcWZERU01V0hHU2kwRnBPSkNHRnR6NTM5XzBhNjBEdDB4YVlPa19QeWdVZWM5clVUMkxxWUtqODk5RzRNMENXZHZuUTdfbS13NlZueHNiN1hzZTRpeUhBVUk0WmcwUFdYU2pvTllpUnUzVnlrUmhiTjY4YmdLclg1bjk0empMS09xZzlYSjE4NndLMTdQbDA2LVRGT3JFbzRfaV92QXZmTFV5dFFhVFhZcnhrcjdtaWhtV2RtUDlraDdYMjZjS0J6blZrWmM2cVIxdUJtWVBJZW5laFRqZTB5SnVWUVBtai1QOWo1QUsxdXdkNmEyTGc?oc=5","date":"2026-03-25","type":"pipeline","source":"Business Wire","summary":"Poxel Confirms the Drawdown Under the Additional Tranche D PDR Bond Issue as Part of the Continuation Plan - Business Wire","headline":"Poxel Confirms the Drawdown Under the Additional Tranche D PDR Bond Issue as Part of the Continuation Plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQSzdGRXlxN0VwY2JscnREbTRqendxQ3E3SEIySHJhTVpEWlNlcF9XLXI4eFc4TjhtLXVGLTU0ZnVCcC0ydXhHSkh2dmk4QzlvRXJsQnFPT1NyTlZybWxZYUc4aDBQSkVYcnoxRVFXeTBpajF1Q09FRU5TM2drLTU0Tno4bFlQN2EzbXpwMThoemNRS2hHdktteFVTNnhTV3JIdXR2LTNZaFZRcVE4ZGhLbkR3bEw2VWUzWlpyemFyLWJrOEM3ZllIejVjV2VmQ2cwNHA2ZWwwejdkbDYwdlFYQXVhNDhHYk5SQjROSQ?oc=5","date":"2026-02-03","type":"pipeline","source":"BioSpace","summary":"Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan - BioSpace","headline":"Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOcGJaU1FvTjBYT1NyS1VDaVVHemwtUlNnMkVpdUdCbzU4SURDa21PRElmRXVWbExMbVVHSWpBTnFhbHBWNnRBdmVJTXZmYTZnNlN0d1BQMVpjZ05MWHFmek5pMlRheUhGNWkxM05Eb3FjUGJmWW5oT0JIR29vaU1aZUw0TVhWd015b29BbnAtNmJPZHAwVGRSVEE1a0pYZGxacUNKMmVFSGlNWllIMjFQM0tkS3FWX1VYXzJyQ0k1T3ZXcXZkdXRmOW03NFFXb3JxblZheW5qcUx6TENnQXQ1dk5pMnhZRXFSY0RGUTRwaTZIVnlKTThrdnFfeE9TNG9oa1VZc2xUV0pyTElfT1dZ?oc=5","date":"2026-01-30","type":"regulatory","source":"Business Wire","summary":"POXEL SA: The Commercial Court of Lyon Approves the Recovery Plan and Brings an End to the Judicial Reorganisation Proceedings - Business Wire","headline":"POXEL SA: The Commercial Court of Lyon Approves the Recovery Plan and Brings an End to the Judicial Reorganisation Proce","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQeHRKb1NCeEFWcEkzV1c2cmRkVVRsdG9kRHRWNDA4cnZLczBnR3VxenlQaWFJWkNCeTZON3BZU1NybWN6elg2UzBWaFdwTVMwdkFKRHowSUNLallTTmhMTjNYUC05ZDZtZmprRGZuZ2JlaXhxb1RnZUpHb2kxbFl6Ykt6VllQSlI3TlE?oc=5","date":"2025-10-31","type":"pipeline","source":"Yahoo Finance","summary":"Appointment of Yves Decadt as Member of Poxel’s Board of Directors - Yahoo Finance","headline":"Appointment of Yves Decadt as Member of Poxel’s Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNYmxxSmh4RzJpVEZiNnZkOERQTWZTek40d2dmN0h2aGtGOXVPWFBrN3VMSEJQV2JmTXF5eGRGR1NfZ1NidWdyYXhldnFzODEydXQzT0tyLXhidXJodG9EOERfbmNPUHhCS25walZwWl9rSXRDY1pVMkZ3RURVMHRPSXpDMjliQXBUUktBeGJJMndJay1CRjhiQUFiSEZKd0FNdjdVS2NHOUxTck1sS0NJV1NjZVFBcTN4bS04WklWTzZhM2FIaEdtaFJDYkQtTkNDckMxWFJ4N3NDaXhNRGNIRQ?oc=5","date":"2025-10-20","type":"pipeline","source":"Business Wire","summary":"Poxel: Availability of a First Document in Response to Questions Received From Shareholders - Business Wire","headline":"Poxel: Availability of a First Document in Response to Questions Received From Shareholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNRzdOSk9QYjdPQlBFbFItbmpMU09FcktoeGlvdW5oay1taG1PNnhpRnpwamxlRV9hU0NsRXEtR1dNZ05mY0VTRHUwR0U3cVc5RGZUQ2VPNmlNN2JzaUVWMVNjeU51Y2htTE9KaHJrSUdmM19acjZvcE5pTXVDazRNRHhOWW03SHYyZTMtMW5jSlVYa3drVUhWMnZteGRWWVRYYUFIeTN4NXczYWV4TkIyTGpWN3V6NGFhdkp1c3p4YTZGZjJCOEV6eUc3OU16UTJtaHRzOWd6VzZBSmE4bExfSmd0R3g0QWlZTFRrS3kzN1Z3aGwtbi1xT0dKWUNGNXdKTE80?oc=5","date":"2025-09-05","type":"pipeline","source":"PR Newswire UK","summary":"GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQQVdkNXJDSGxPNTVxM2haWVplU3ZFMVprajl5aHhycjcxUHJyUlJTLW13c2VUdElNVzlGbENvNW40Y2x2OXBMTjBUXzZYLWlURkRoVWwyTHlJdW5OakNnQ1o2T2lSZVJDZzlGU3Zrcmd6UDRxeWFYT0Rka0pRdWdmcGhOZHNUbFp5QkZGbWo0RGZoRUIzZWlWVTZNWk9TaGRBdWMxbGphYklkbEhFQTZsU18tYUJnVkc1clRremtoYTBrLXFCck5Edk1B?oc=5","date":"2025-07-01","type":"pipeline","source":"BioSpace","summary":"Poxel Announces Postponement of its Annual General Meeting and Provides a Corporate Update - BioSpace","headline":"Poxel Announces Postponement of its Annual General Meeting and Provides a Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOaGMwZmh0SWVNM2V1elF0Ykx4R2FyWTc3emlSckwzUmg5QUEtYmpnSDFyQmJiVWI2czhPM1JXdW50UnAyamNOT1FCSXVrNm1ma1BSVldDbnlNbUNleXR4bWRNWmtTZUhyT05DVHlKdDd0S3U5U0dQVXZiV3NJTW5vdkFYSzVOektrVXRBWVplYjQ3UmNVZWd2VVRUQmhHT0k0bjFUVk13NDNETjJmSXh1TFczMm1uWWZJTU1HN25FUWgwdW9mc1ZLWl9iT0RTWWdlWFpkeVpZOWtGUnQ3eWRNUVZZeGJIQ2puSzBTclF5WExQYnAyQktkVWxIbFBQWEtKN1VXZjVTZ21mN1BlZ0QxanJnMmhfeDA2?oc=5","date":"2025-01-30","type":"pipeline","source":"PR Newswire","summary":"Metabolic Dysfunction-Associated Steatohepatitis Market to Register Stunning Growth at a CAGR of 17.9% in the US by 2034 | DelveInsight - PR Newswire","headline":"Metabolic Dysfunction-Associated Steatohepatitis Market to Register Stunning Growth at a CAGR of 17.9% in the US by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE56eEQ0XzlCYW5wZ25qZTNDenNvT0JKcHBnS1lNQlhENTBuSzlVSlg2SXF5Uy1QYmNRVy1sY3hyYURsQUp5Y1N1cnNlRkpjaTA?oc=5","date":"2024-12-08","type":"pipeline","source":"eToro","summary":"Poxel SA (POXEL.PA) Stock Price, News & Analyst Forecast - eToro","headline":"Poxel SA (POXEL.PA) Stock Price, News & Analyst Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPSjZnSFpFUjNEWkNVT0xkeTVHR2h0TXlmOHdiSzlBNHhJanJPMWxzSzhwdjZ6ZDlfQl9rbFdvTjNZS2tUWnJaTFBHakpicld4OXpsTW96Q3V3X1RzcFc0MHhocm54MUowWUNrMGR4dGtzR2NLamQwRmZobTUza2xZeG0wX3NvQXJxd2g5cVp4VHNfQTRpWmhDZnZXX0JBNTVsQzhCMjM3c3p0anM?oc=5","date":"2021-09-10","type":"pipeline","source":"BioSpectrum Asia","summary":"French firm Poxel launches type 2 diabetes drug in Japan - BioSpectrum Asia","headline":"French firm Poxel launches type 2 diabetes drug in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNOVhjSUxadWlnSmdIb0ZyRGNnOHFwOVRRRk9TYUZzM204TUNrc3RjRUJEVmhIWFVVWWJ0a2IwaGFlOVlwUHB2b2lwS05CV0ZMVlRxajZRMkNmM0JKZWt0UllpY2laVmhkeUFKSU1lRi1ZS3lsREpzQ2xrWlhIZzRpbE9pREgyUGRwdUlUVU1OZ1BiLVBJbDF3?oc=5","date":"2021-09-02","type":"pipeline","source":"citybiz","summary":"Poxel Appoints Elizabeth Woo as Senior Vice President - citybiz","headline":"Poxel Appoints Elizabeth Woo as Senior Vice President","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}